Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed)
Through this non-competitive single source cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application from (-----institute name-----) with the intent of funding a single award to continue to support the AIDS and Cancer Specimen Resource (ACSR).
This is a reissue of RFA-CA-18-01 2. The ACSRs mission is to address the specimen needs of clinician and basic researchers in HIV and HIV-associated malignancy research.
The ACSR is an international repository with specimens that reflect different eras of the epidemic (notably pre-cART and post-cART), different regions of the world, and people of diverse genetic backgrounds with different environmental exposures.
Specimens have been obtained from people with HIV (PWH), people at risk for acquiring HIV, and HIV-uninfected controls.
Specimens have been obtained from participants in clinical trials, observational cohort studies, or other research studies conducted by HIV investigators and consortium.
The ACSR uses informed approaches to prospectively curate specimens in the USA, sub-Saharan Africa and Latin America that will be most valuable for the research community.
Specimens and associated data are made available to the research community-at-large at NO COST.
A second key role of the ACSR, is to serve as the AMC Biorepository for the AIDS Malignancy Consortium (AMC).
The AMC is an NCI funded, multicenter clinical trials cooperative group that performs clinical trials research in the treatment and prevention of HIV-associated malignancies.
The ACSR is currently providing support for domestic (two), sub-Saharan African, and Latin American biorepositories for the AMC.
This is a reissue of RFA-CA-18-01 2. The ACSRs mission is to address the specimen needs of clinician and basic researchers in HIV and HIV-associated malignancy research.
The ACSR is an international repository with specimens that reflect different eras of the epidemic (notably pre-cART and post-cART), different regions of the world, and people of diverse genetic backgrounds with different environmental exposures.
Specimens have been obtained from people with HIV (PWH), people at risk for acquiring HIV, and HIV-uninfected controls.
Specimens have been obtained from participants in clinical trials, observational cohort studies, or other research studies conducted by HIV investigators and consortium.
The ACSR uses informed approaches to prospectively curate specimens in the USA, sub-Saharan Africa and Latin America that will be most valuable for the research community.
Specimens and associated data are made available to the research community-at-large at NO COST.
A second key role of the ACSR, is to serve as the AMC Biorepository for the AIDS Malignancy Consortium (AMC).
The AMC is an NCI funded, multicenter clinical trials cooperative group that performs clinical trials research in the treatment and prevention of HIV-associated malignancies.
The ACSR is currently providing support for domestic (two), sub-Saharan African, and Latin American biorepositories for the AMC.
Related Programs
Department of Health and Human Services
Department of Health and Human Services
Department of Health and Human Services
Cancer Cause and Prevention Research
Department of Health and Human ServicesCancer Detection and Diagnosis Research
Department of Health and Human ServicesDepartment of Health and Human Services
Department of Health and Human Services
Department of Health and Human Services
Agency: Department of Health and Human Services
Office: National Institutes of Health
Estimated Funding: $0
Office: National Institutes of Health
Estimated Funding: $0
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-043.html
Additional Information of Eligibility:
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
See full Notice of Funding Opportunity for additional details on eligibility.
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-043.html
Contact:
Agency Email Description:
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Agency Email:
Date Posted:
2023-11-02
Application Due Date:
Archive Date:
2024-02-14
Social Entrepreneurship
Spotlight
Partnerships in Social Enterprises Can Increase Social Impact
Chief executive of HCT, Dai Powell, shares the experiences and practical lessons he learned along the way when teaming up with Ealing Community Transport to deliver site transport during the Olympic Park construction.
Learn How to Identify and Avoid Grant Scams
